Publication
Article
Supplements and Featured Publications
Current and Emerging Trends in Chronic Myeloid LeukemiaVolume1 Issue 1
Current and Future Trends in Chronic Myeloid Leukemia
This publication includes a summary of data on therapeutic agents for the current and future treatment landscape of chronic myeloid leukemia. Hematologic oncology experts provide key insights on approaching disease management, including a discussion on treatment options through later-line settings.
Articles in this issue
Current and Future Trends in Chronic Myeloid Leukemia
Dr. Hobbs on the Role of Molecular Testing to Determine Resistance in CML
Dr. Jabbour on Selecting Ponatinib After Second-Generation TKI Failure in CML
Dr. Cortes on the Future of Ponatinib in CML Treatment
Dr. Sweet on Key Findings From the OPTIC Trial With Ponatinib in CML
Dr. Sweet on the Awareness and Mitigation of AEs Associated With Ponatinib in CML
Dr. Hobbs on Choosing Optimal Second-Line Treatment Option for TKI-Resistant CLL
Dr. Cortes on Navigating Among Frontline TKIs in the CML Paradigm
Dr. Jabbour on the ASCEMBL Data With Asciminib in Chronic-Phase CML
Dr. Hobbs on Managing Ponatinib-Associated Toxicities in CML
Dr. Sweet on Treatment Selection With TKIs in CML
Related Videos
Related Content
